In contrast to the intrinsic TCR affinity of distinct clonotypes and the clonotypic diversity in an individual, manipulating the degree of B-cell activation or antigen presentation to CD4+ T cells, might provide a more amenable way of controlling the antigen-specific TCR repertoire during infection, vaccination or autoimmunity. This evidence concerns the gene CD4 and Autoimmunity.